 |
ALX Oncology
Last updated: August 05, 2025
Founder Jaume Pons
USA | Funding: $329.2M (+)
Website: http://alxoncology.com/
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
Website: http://alxoncology.com/
ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer.
